Treatment of symptomatic uterine fibroids with orally active gonadotropin-releasing hormone antagonists and add-back therapy

被引：0
|
作者：
Felberbaum, Ricardo [1 ]
Kupker, Wolfgang [2 ]
Diedrich, Klaus [3 ]
机构：
[1] Klinikverbund Allgau gGmbH, Klin Frauenheilkunde & Geburtshilfe, Klinikum Kempten & Klin Immenstadt, KinderWunschKempten KWK,Zent Gynakol Endokrinol &, Robert Weixler Str 50, D-87439 Kempten, Germany
[2] IVF Baden Baden, Zent Reprod Med & Gynakol Endokrinol, Baden Baden, Germany
[3] Univ Klinikum Schleswig Holstein, Klin Frauenheilkunde & Geburtshilfe, Campus Lubeck, Lubeck, Germany
来源：
GYNAKOLOGISCHE ENDOKRINOLOGIE | 2023年 / 21卷 / 02期
关键词：
LEIOMYOMAS;
D O I：
10.1007/s10304-023-00505-6
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：128 / 131
页数：4
相关论文
共 50 条
  • [21] TREATMENT OF UTERINE FIBROIDS WITH IMPLANTS OF GONADOTROPIN-RELEASING HORMONE AGONIST - ASSESSMENT BY HYSTEROGRAPHY
    DONNEZ, J
    SANDOW, J
    SCHRURS, B
    CLERCKX, F
    GILLEROT, S
    FERTILITY AND STERILITY, 1989, 51 (06) : 947 - 950
  • [22] Prospective randomized study of the effect of "Add-back" hormone replacement on vascular function during treatment with gonadotropin-releasing hormone agonists
    Yim, SF
    Lau, TK
    Sahota, DS
    Chung, TKH
    Chang, AMZ
    Haines, CJ
    CIRCULATION, 1998, 98 (16) : 1631 - 1635
  • [23] At last, an orally active gonadotropin-releasing hormone antagonist
    Paulson, Richard J.
    FERTILITY AND STERILITY, 2019, 111 (01) : 30 - 31
  • [24] TREATMENT WITH THE GONADOTROPIN-RELEASING HORMONE-AGONIST GOSERELIN BEFORE HYSTERECTOMY FOR UTERINE FIBROIDS
    LUMSDEN, MA
    WEST, CP
    THOMAS, E
    COUTTS, J
    HILLIER, H
    THOMAS, N
    BAIRD, DT
    BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1994, 101 (05): : 438 - 442
  • [25] Hormonal Add-Back Therapy for Females Treated With Gonadotropin-Releasing Hormone Agonist for Endometriosis: A Randomized Controlled Trial EDITORIAL COMMENT
    DiVasta, Amy D.
    Feldman, Henry A.
    Gallagher, Jenny Sadler
    Stokes, Natalie A.
    Laufer, Marc R.
    Hornstein, Mark D.
    Gordon, Catherine M.
    OBSTETRICAL & GYNECOLOGICAL SURVEY, 2015, 70 (11) : 693 - 694
  • [26] Effects of add-back therapy on bone mineral density and pyridinium crosslinks in patients with endometriosis treated with gonadotropin-releasing hormone agonists
    Gnoth, C
    Gödtke, K
    Freundl, G
    Godehardt, E
    Kienle, E
    GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 1999, 47 (01) : 37 - 41
  • [27] The Effects of Gonadotropin-Releasing Hormone Agonist Combined with Add-Back Therapy on Quality of Life for Adolescents with Endometriosis: A Randomized Controlled Trial
    Gallagher, Jenny Sadler
    Feldman, Henry A.
    Stokes, Natalie A.
    Laufer, Marc R.
    Hornstein, Mark D.
    Gordon, Catherine M.
    DiVasta, Amy D.
    JOURNAL OF PEDIATRIC AND ADOLESCENT GYNECOLOGY, 2017, 30 (02) : 215 - 222
  • [28] Gonadotropin-releasing hormone antagonist (relugolix) for treatment of uterine adenomyosis with symptomatic endometriosis
    Matsushima, Takashi
    Nagashima, Asako
    Harigane, Eika
    Watanabe, Asako
    Shinmura, Hiroki
    Ouchi, Nozomi
    Kurashina, Ryuhei
    Suzuki, Shunji
    Iida, Shinya
    JOURNAL OF ENDOMETRIOSIS AND PELVIC PAIN DISORDERS, 2024, 16 (02) : 112 - 116
  • [29] Therapeutic effect and underlying mechanism of Gonadotropin-releasing hormone in uterine fibroids
    Gong, Y. F.
    Han, W.
    Cui, Y.
    Li, L. Y.
    Lu, L. Y.
    Ren, C. N.
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2020, 34 (04): : 1437 - 1443
  • [30] Evaluation of different add-back estradiol and progesterone treatments to gonadotropin-releasing hormone agonist treatment in patients with premenstrual dysphoric disorder
    Segebladh, Birgitta
    Borgstrom, Anna
    Nyberg, Sigrid
    Bixo, Marie
    Sundstrom-Poromaa, Inger
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2009, 201 (02) : 139.e1 - 139.e8
12345